Leadership

Curogen’s Leadership is consisted with professional executive members with biotechnology and pharmaceutical backgrounds, collective experience, and broad visions for the future. Each one of our members leads us to broadening and developing our pipeline, and paves Curogen’s way into contributing to humanity’s health.

CEO

Chang-Woo Lee, Ph.D. CEO

Chang-Woo Lee, Ph.D.
CEO

  • · Harvard Medical School, Post-doctor
  • · Univ of Glasgow/NIMR, PhD
  • · SKKU MED, Professor
  • · Ministry of Health and Welfare, Ministry of Trade, Industry and Energy, Ministry of Science and Technology: Advisory committee, Steering committee, Expert committee
  • · Invited talk at Harvard Medical school, Mayo Clinic, Oxford Univ, etc
  • · 2004~2023, Average SCI IF 17.075 for 20 selected journal publications as corresponding author

Executive Team

  • Jehoon Yang

    Jehoon Yang

    Chief Medical Officer

    Gyeongsang National University, DVM/PhD

    National Institutes of Health

    Asan Medical Center

    Samsung Medical Center

  • Myungsoon Yang

    Myungsoon Yang

    Head of Clinical Research

    Ajou University, PhD

    5T International Patent Law Firm

    Emory University

  • Hyun-Soo Kim

    Hyun-Soo Kim

    Chief R&D Officer

    Sungkyunkwan University School of Medicine, PhD

    Samsung Biomedical Research Institute

     

     

  • Jeongho Kwon

    Jeongho Kwon

    Head of R&D Strategy

    KAIST, PhD

    Samsung Biomedical Research Institute

     

     

  • Jihyun Choi

    Jihyun Choi

    Division Leader of Drug Design and Synthesis

    University of Science & Technology, MS

    Institut Pasteur Korea

Board of Directors

  • Jaeyeol An

    Partners Investment, Managing Director

    Seoul National University, MSc

    Genexine, Project Manager

    Samsung Medical Center, Researcer

     

  • Kiho Choi

    Sungkyunkwan University, Global Entrepreneur Graduate School, Professor

    Yonsei University, MBA

    Stanford Research Institute International, Country Manager

    Sales&Marketing Group of Intel Korea, GM

    Strategic Investment Group of Intel Capital, MD

    Samsung Electronics, Export Manager

    Samsung Electronics, S/W Application Engineer

  • Heounjeong Go

    University of Ulsan College of Medicine, Asan Medical Center, Department of Pathology, Professor

    Seoul National University, School of Medicine, MD/PhD

    Seoul National University Hospital, Department of Pathology, Resident and Fellow Doctor

  • Sungjune Hong

    Genexine Inc., President

    Yonsei University, MBA

    Vanderbilt Law School, LLM

    KICPA/AICPA/New York Bar Member

    Daewoo Motors, Finance Manager

    Philip Morris, Finance Manager

    Nike Korea, CFO

    Handok, CFO

    Rokit Healthcare, President & COO

     

  • Hyunsoo Kim

    Attorney at Law/Audit

    Sungkyunkwan Univeresity, Law School

    Hanhwa, Attorney at Law

Scientific Advisory Board

Clinical Studies

  • Mi-La Cho, PhD

    The Catholic University of Korea, College of Medicine, Department of Medical Life Science, professor

    Autoimmune Disease

  • Sung-Hwan Park, MD/PhD

    The Catholic University of Korea Seoul St. Mary's Hospital, Division of Rheumatology, Professor

    Autoimmune Disease, Rheumatology

  • ChangMin Kim, MD/PhD

    Korean Association for the Study of the Liver, Past President

    NASH/HCC

  • Heounjeong Go, MD/PhD

    Professor, University of Ulsan College of Medicine, Asan Medical Center, Department of Pathology

    Clinical Pathology

Preclinical Studies

  • Ho Lee, PhD

    National Cancer Center, Graduate School of Cancer Science and Policy, Professor

    Preclinical Animal Models

  • Ji-Woo Lee, DVM

    Director of Pohang Animal Hospital

    Preclinical Animal Models

  • Kyunghoon Lee, MD/PhD

    Sungkyunkwan University, School of Medicine, Department of Anatomy & Cell Biology, Professor

    Anatomy Pathology, Neuroscience

  • Yoon Jeon, PhD

    National Cancer Center, Research Core Center, Laboratory Animal Research Facility, Researcher

    Preclinical Animal Models

Scientific Studies

  • Sang-Gu Hwang, PhD

    Korea Institute of Radiological & Medical Sciences, Division of Radiation Cancer Biology, Principal Investigater

    Biochemistry, Molecular Biology, Radiobiology

  • Myong-Joon Hahn, MD/PhD

    Sungkyunkwan University, School of Medicine, Department of Molecular Cell Biology, Professor

    Molecular Medicine

  • Hyung-Ho Ha, PhD

    Sunchon National University, College of Pharmacy, Professor

    Medicinal Chemistry

  • Kyeong Sook Choi, PhD

    Ajou University, School of Medicine, Department of Biochemistry & Molecular Biology, Professor

    Molecular Medicine, Tumor Biology

  • Hyeseong Cho, PhD

    Ajou University, School of Medicine, Department of Biochemistry & Molecular Biology, Professor Emeritus

    Molecular Medicine

  • Hyun-Soo Cho, PhD

    Yonsei University, Department of Systems Biology, Professor

    Therapeutic Proteins

  • Jang-Soo Chun, PhD

    Gwangju Institute of Science and Technololgy, School of Life Sciences, Professor

    Degenerative Disease

  • Hyun-Ju Park, PhD

    Sungkyunkwan University, School of Pharmacy, Professor

    Medicinal Chemistry, Computer-Aided Drug Design

  • Eunae Kim, PhD

    Chosun University, College of Pharmacy, Professor

    Medicinal Chemistry, Computational Chemistry

  • Myung-Hee Kwon, PhD

    Ajou University School of Medicine, Department of Microbiology, Professor

    Antibody Drugs